Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Exercise  COVID-19 treatment studies for Exercise  C19 studies: Exercise  Exercise   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Baseline physical activity and the risk of severe illness and mortality from COVID-19: A dose–response meta-analysis
Liu et al., Preventive Medicine Reports, doi:10.1016/j.pmedr.2023.102130 (meta analysis)
Liu et al., Baseline physical activity and the risk of severe illness and mortality from COVID-19: A dose–response.., Preventive Medicine Reports, doi:10.1016/j.pmedr.2023.102130 (meta analysis)
Feb 2023   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Meta analysis of 14 studies showing a negative dose-response relationship between the level of physical activity and COVID-19 severity and mortality.
Currently there are 53 exercise studies and meta analysis shows:
OutcomeImprovement
Mortality50% lower [39‑60%]
Ventilation46% lower [32‑57%]
ICU admission41% lower [35‑47%]
Hospitalization36% lower [28‑43%]
Cases19% fewer [7‑29%]
Liu et al., 11 Feb 2023, peer-reviewed, 3 authors.
Contact: songtaozhenzhen@sina.com.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperExerciseAll
Abstract: Preventive Medicine Reports 32 (2023) 102130 Contents lists available at ScienceDirect Preventive Medicine Reports journal homepage: www.elsevier.com/locate/pmedr Review article Baseline physical activity and the risk of severe illness and mortality from COVID-19: A dose–response meta-analysis Junjie Liu a, 1, Zhiguang Guo b, 1, Songtao Lu a, * a b School of Sports, Wuhan University of Science and Technology, Wuhan 430081, China School of Sports Health, HuBei University of Chinese Medicine. Wuhan 430081, China A R T I C L E I N F O A B S T R A C T Keywords: Physical activity COVID-19 Mortality Severe illness Meta-analysis Dose–response To provide a scientific basis for improved exercise-based immunity, a meta-analysis was used to explore the dose–response relationship between physical activity (PA) and the risk of severe illness and mortality related to COVID-19 (coronavirus disease 2019). To this end, we searched PubMed, Web of Science databases from January 2020 through April 2022. 14 observational studies met the criteria for inclusion in the meta-analysis, including 2840 cases of severe illness and death from COVID-19. Categorical dose–relationship analysis showed that the risks of severe illness and mortality from COVID-19 were, respectively, 46% (risk ratio (RR): 0.54; confidence intervals (CIs): 0.41–0.68) and 59% (RR = 0.41; 95%CI: 0.23–0.58) lower for the highest dose of PA compared with the lowest dose of PA. The results of the continuous dose–response analysis show an inverse nonlinear relationship (Pnon-linearity < 0.05) between PA and both the risk of severe illness and mortality from COVID-19. For PA below 10 MET-h/week (MET-h/week: metabolic equivalent of task-hours/week), an increase of 4 MET-h/ week (1 h of moderate-intensity or 0.5 h of high-intensity PA) was associated with 8% and 11% reductions in the risk of severe illness and mortality from COVID-19. PA above 10 MET-h/week lowered the risk of severe illness and mortality from COVID-19 by 7% and 9%, respectively, for each 4 MET-h/week increase. Doses of WHOrecommended PA levels (10 MET-h/week) may be required for more substantial reductions in the risk of se­ vere illness and mortality from COVID-19.
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit